These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 18520165)
1. Coexisting cholinergic and parahippocampal degeneration: a key to memory loss in dementia and a challenge for transgenic models? Cassel JC; Mathis C; Majchrzak M; Moreau PH; Dalrymple-Alford JC Neurodegener Dis; 2008; 5(5):304-17. PubMed ID: 18520165 [TBL] [Abstract][Full Text] [Related]
2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
3. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475 [TBL] [Abstract][Full Text] [Related]
4. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Mufson EJ; Counts SE; Perez SE; Binder L Neuropeptides; 2005 Jun; 39(3):233-7. PubMed ID: 15893372 [TBL] [Abstract][Full Text] [Related]
5. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy. Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006 [TBL] [Abstract][Full Text] [Related]
6. Memory deficits in amyotrophic lateral sclerosis patients with dementia and degeneration of the perforant pathway A clinicopathological study. Takeda T; Uchihara T; Mochizuki Y; Mizutani T; Iwata M J Neurol Sci; 2007 Sep; 260(1-2):225-30. PubMed ID: 17561122 [TBL] [Abstract][Full Text] [Related]
7. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993 [TBL] [Abstract][Full Text] [Related]
8. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Zhang Q; Zhang X; Sun A Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923 [TBL] [Abstract][Full Text] [Related]
9. Reduction in hippocampal cholinergic innervation is unrelated to recognition memory impairment in aged rhesus monkeys. Calhoun ME; Mao Y; Roberts JA; Rapp PR J Comp Neurol; 2004 Jul; 475(2):238-46. PubMed ID: 15211464 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic strategies and Alzheimer's disease: contribution of animal models]. Chabrier PE Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893 [TBL] [Abstract][Full Text] [Related]
11. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827 [TBL] [Abstract][Full Text] [Related]
12. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674 [TBL] [Abstract][Full Text] [Related]
13. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
15. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338 [TBL] [Abstract][Full Text] [Related]
16. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H; Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444 [TBL] [Abstract][Full Text] [Related]